Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients

EJNMMI Research

Table 3 Values from pathological findings (N = 55)

Volume of Interest	N	SUV_mean* (g/mL)	SUV_max* (g/mL)	100 × MR_FDG* (µmol/g/min)	100 × K_i * (mL/mL/min)	DV_FDG* (%)
Gastrointestinal cancer	4	8.83 [6.58–14.70]	15.52 [12.06–25.40]	23.53 [14.72–31.49]	4.31 [2.78–7.32]	244.70 [125–360.40]
Head and neck cancer	8	9.57 [5.19–22.00]	17.02 [9.69–39.57]	26.86 [11.47–68.31]	4.14 [2.12–11.02]	236.90 [88.61–620.30]
Infection and Inflammation	13	4.60 [2.54–9.33]	9.14 [4.67–17.88]	14.85 [3.59–38.44]	2.46 [0.84–6.41]	126.70 [50.98–230]
Lung adenocarcinoma	14	9.88 [1.38–24.3]	15.07 [2.47–35.52]	28.53 [4.05–77.55]	5.06 [0.53–14.36]	278.00 [43.38–762]
Lung squamous cell carcinoma	9	14.30 [7.33–28.60]	21.59 [2.45–44.48]	31.27 [16.84–55.55]	5.49 [3.01–10.48]	272.90 [114–592]
Lymphoma	7	7.40 [4.64–17.80]	13.49 [8.05–34.50]	23.13 [9.77–68.51]	4.03 [1.74–12.46]	248.80 [102.10–938]

*Values are median [min–max]
Note that MR_FDG and K_i values are multiplied by 100. Lumped constant = 1
SUV_max is included for comparison, as it is the most used PET metric in clinical practice